DASA3 Stock Overview
Provides diagnostic and hospital services in Brazil and Argentina.
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 3/6 |
| Past Performance | 0/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
Diagnósticos da América S.A. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | R$2.99 |
| 52 Week High | R$13.56 |
| 52 Week Low | R$2.51 |
| Beta | 0.36 |
| 11 Month Change | 10.74% |
| 3 Month Change | -21.52% |
| 1 Year Change | -71.92% |
| 33 Year Change | -93.90% |
| 5 Year Change | -90.00% |
| Change since IPO | -50.17% |
Recent News & Updates
Revenues Working Against Diagnósticos da América S.A.'s (BVMF:DASA3) Share Price Following 27% Dive
Aug 15
Diagnósticos da América (BVMF:DASA3) Use Of Debt Could Be Considered Risky
Jul 23Recent updates
Revenues Working Against Diagnósticos da América S.A.'s (BVMF:DASA3) Share Price Following 27% Dive
Aug 15Diagnósticos da América (BVMF:DASA3) Use Of Debt Could Be Considered Risky
Jul 23Benign Growth For Diagnósticos da América S.A. (BVMF:DASA3) Underpins Stock's 30% Plummet
Jun 24Why Investors Shouldn't Be Surprised By Diagnósticos da América S.A.'s (BVMF:DASA3) 25% Share Price Plunge
May 10Risks To Shareholder Returns Are Elevated At These Prices For Diagnósticos da América S.A. (BVMF:DASA3)
Mar 21Diagnósticos da América (BVMF:DASA3) May Have Issues Allocating Its Capital
Feb 04Is Diagnósticos da América (BVMF:DASA3) A Risky Investment?
Jan 08Insufficient Growth At Diagnósticos da América S.A. (BVMF:DASA3) Hampers Share Price
Dec 18Diagnósticos da América (BVMF:DASA3) Is Reinvesting At Lower Rates Of Return
Sep 20Is Diagnósticos da América (BVMF:DASA3) Using Too Much Debt?
Aug 25Diagnósticos da América S.A. (BVMF:DASA3) Looks Inexpensive But Perhaps Not Attractive Enough
Jun 27Diagnósticos da América (BVMF:DASA3) May Have Issues Allocating Its Capital
Apr 17Diagnósticos da América (BVMF:DASA3) Seems To Be Using A Lot Of Debt
Mar 13Returns On Capital At Diagnósticos da América (BVMF:DASA3) Paint A Concerning Picture
Dec 14Does Diagnósticos da América (BVMF:DASA3) Have A Healthy Balance Sheet?
Nov 09Diagnósticos da América (BVMF:DASA3) May Have Issues Allocating Its Capital
Aug 19Here's Why Diagnósticos da América (BVMF:DASA3) Has A Meaningful Debt Burden
Jul 15Diagnósticos da América (BVMF:DASA3) May Have Issues Allocating Its Capital
May 06Results: Diagnósticos da América S.A. Delivered A Surprise Loss And Now Analysts Have New Forecasts
Apr 01These 4 Measures Indicate That Diagnósticos da América (BVMF:DASA3) Is Using Debt Reasonably Well
Mar 02Diagnósticos da América (BVMF:DASA3) Could Be Struggling To Allocate Capital
Jan 25Diagnósticos da América (BVMF:DASA3) Might Be Having Difficulty Using Its Capital Effectively
Oct 10Is Diagnósticos da América (BVMF:DASA3) A Risky Investment?
Sep 13There Are Reasons To Feel Uneasy About Diagnósticos da América's (BVMF:DASA3) Returns On Capital
Jun 27Diagnósticos da América (BVMF:DASA3) Has A Somewhat Strained Balance Sheet
May 31We're Watching These Trends At Diagnósticos da América (BVMF:DASA3)
Feb 25Shareholders of Diagnósticos da América (BVMF:DASA3) Must Be Delighted With Their 634% Total Return
Jan 03
These 4 Measures Indicate That Diagnósticos da América (BVMF:DASA3) Is Using Debt Extensively
Dec 07Shareholder Returns
| DASA3 | BR Healthcare | BR Market | |
|---|---|---|---|
| 7D | -9.4% | -4.1% | 0.02% |
| 1Y | -71.9% | -7.0% | 9.4% |
Return vs Industry: DASA3 underperformed the BR Healthcare industry which returned -7.2% over the past year.
Return vs Market: DASA3 underperformed the BR Market which returned 9.3% over the past year.
Price Volatility
| DASA3 volatility | |
|---|---|
| DASA3 Average Weekly Movement | 12.0% |
| Healthcare Industry Average Movement | 7.6% |
| Market Average Movement | 4.6% |
| 10% most volatile stocks in BR Market | 9.1% |
| 10% least volatile stocks in BR Market | 2.3% |
Stable Share Price: DASA3's share price has been volatile over the past 3 months.
Volatility Over Time: DASA3's weekly volatility (12%) has been stable over the past year, but is still higher than 75% of BR stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1961 | n/a | Licio Tavares Cintra | www.dasa3.com.br |
Diagnósticos da América S.A., together with its subsidiaries, provides diagnostic and hospital services in Brazil and Argentina. It operates through Hospitals and Oncology; Diagnostics and Care Coordination; and Diagnostics – International Operations segments. The company offers outpatient doctors; medical and outpatient services; diagnostic support assistants for private patients or partner companies; care coordination, remote monitoring, population health management, home medical, and paramedical services; and medical consultations.
Diagnósticos da América S.A. Fundamentals Summary
| DASA3 fundamental statistics | |
|---|---|
| Market cap | R$2.23b |
| Earnings (TTM) | -R$971.87m |
| Revenue (TTM) | R$14.77b |
0.2x
P/S Ratio-2.3x
P/E RatioIs DASA3 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| DASA3 income statement (TTM) | |
|---|---|
| Revenue | R$14.77b |
| Cost of Revenue | R$10.81b |
| Gross Profit | R$3.96b |
| Other Expenses | R$4.93b |
| Earnings | -R$971.87m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
Nov 13, 2024
| Earnings per share (EPS) | -1.30 |
| Gross Margin | 26.79% |
| Net Profit Margin | -6.58% |
| Debt/Equity Ratio | 159.7% |
How did DASA3 perform over the long term?
See historical performance and comparison